Cumulatively these findings suggested that TD was related to phenylalanine metabolism and thus that sequence variants in the gene for phenylalanine hydroxylase ( PAH ) , the rate-limiting enzyme in the catabolism of phenylalanine , could be associated with TD susceptibility .